이번 주 새 소식 🆕 최근 업데이트
이 논문의 관계도
List view
Current PaperWhatsOverviews · Chest
Neoadjuvant / Perioperative Immunotherapy연결 근거: perioperative, resectable
- Methods방법론 색인 — 어떤 분석을 어떤 논문이 썼나연결어: neoadjuvant, perioperative, resectable
- ReviewClinical Oncology 종합 리뷰연결어: neoadjuvant, perioperative, resectable
- Statistics통계 방법론 리뷰연결어: neoadjuvant, perioperative, resectable
- Yang 2024Treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer…연결어: neoadjuvant, perioperative, resectable
- EvidenceEvidence table — 임상 논문 핵심 결과연결어: neoadjuvant, perioperative, resectable
- +56 more
Thoracic CT / PET Imaging연결 근거: ct, pulmonary, lung transplantation
- Methods방법론 색인 — 어떤 분석을 어떤 논문이 썼나연결어: ct, pet, pulmonary
- ReviewClinical Pulmonology 종합 리뷰연결어: ct, pet, pulmonary
- DeFreitas 2021Complications of Lung Transplantation: Update on Imaging Manifestations and Management연결어: ct, pet, pulmonary
- Cottin 2016Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)연결어: ct, pulmonary, egpa
- ReviewBiomedical Imaging 종합 리뷰연결어: ct, pet, pulmonary
- +107 more
Shared Tags이 논문의 tags: CCRT, NSCLC, chemotherapy, immunotherapy, perioperative
- Spigel 2022Five-Year Survival Outcomes From the PACIFIC Trial Durvalumab After Chemoradiotherapy in Stage…공유 tag: CCRT, NSCLC, chemotherapy, immunotherapy
- Yuichiro Takeda 2022The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy fol…공유 tag: CCRT, NSCLC, chemotherapy, immunotherapy
- Naidoo 2023Brief Report Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC A P…공유 tag: CCRT, NSCLC, chemotherapy, immunotherapy
- Mooradian 2024Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non–Small Cell Lung…공유 tag: CCRT, NSCLC, chemotherapy, immunotherapy
- Dong Young Jeong 2025Unraveling the tumor-microenvironment through a radiogenomic-based multiomic approach to predic…공유 tag: NSCLC, chemotherapy, immunotherapy
- +129 more
최근 7일(2026-11-08 이후) 동안 추가·갱신된 것들입니다. RSS로도 구독할 수 있습니다.
추가·갱신된 논문
이번 기간에 갱신된 논문이 없습니다.
갱신된 리뷰
- 2026-11-15 · 방법론 색인 — 어떤 분석을 어떤 논문이 썼나
- 2026-11-15 · 메타데이터 점검
- 2026-11-15 · Evidence table — 임상 논문 핵심 결과
- 2026-11-08 · 이번 주 새 소식
새 screening 후보
> Open access 논문은 📎 Zotero에 추가 링크를 열고 브라우저의 Zotero Connector로 저장하세요.
- 2026-11-15 · TROP-2-Directed ADC Could Be New Standard for Some NSCLCs. — include
- 2026-11-15 · OPXrayNet: a high-precision, explainable AI framework for transformative opportunistic osteoporosis screening utilizing multi-site X-ray imaging. — include · 📎 Zotero에 추가 (OA/hybrid)
- 2026-11-15 · Vaccines could be a new frontier in KRAS targeting. — include
- 2026-11-15 · Navigating treatment for De novo oligometastatic breast cancer: The Assisi think tank meeting. — include · 📎 Zotero에 추가 (OA/hybrid)
- 2026-11-15 · Historical and projected smoking patterns and lung cancer incidence across sex and birth-cohorts in Spain: The rising burden in women. — include · 📎 Zotero에 추가 (OA/hybrid)
- 2026-11-15 · Characteristics and outcomes of patients with advanced or metastatic non-small cell lung cancer harboring a HER2-activating mutation: a real-world retrospective cohort study using a US clinico-genomic database. — include
- 2026-11-15 · PARP inhibitors in breast cancer: From DNA repair targeting to next-generation precision therapeutics. — include
- 2026-11-15 · Particle therapy for T3N0M0 non-small cell lung cancer: a Japanese nationwide prospective registry study. — include · 📎 Zotero에 추가 (OA/hybrid)
- 2026-11-15 · Local and systemic inflammatory and immune pathways in anaplastic thyroid carcinoma: emerging therapeutic targets. — include · 📎 Zotero에 추가 (OA/hybrid)
- 2026-11-15 · Patient factors affecting unplanned admission or emergency department attendance following systemic anti-cancer therapy for advanced non-small cell lung cancer: A population-based retrospective cohort study. — include
- 2026-11-15 · Exponential growth and slow-growing tumours in screen-detected lung cancers: findings from the NELCIN-B3 LDCT screening study in China. — include · 📎 Zotero에 추가 (OA/hybrid)
- 2026-11-15 · Perioperative Camrelizumab Plus Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Randomized Clinical Trial. — include · 📎 Zotero에 추가 (PMC)
- 2026-11-15 · Integrating Chemotherapy With Immunotherapy Prior to Surgery for Patients With Locally Advanced HNSCC. — include
- 2026-11-15 · Izalontamab Brengitecan in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: Research Summary. — include
- 2026-11-15 · Izalontamab Brengitecan in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: The PANKU-Esophagus01 Randomized Clinical Trial. — include
- 2026-11-08 · Multi-omics reveals PCSK9 induces precursor-like macrophage M2 polarization to exacerbate immunosuppression in peritoneal metastasis. — include · 📎 Zotero에 추가 (OA/gold)
- 2026-11-08 · Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of multiple myeloma, version 2.0. — include · 📎 Zotero에 추가 (OA/gold)
- 2026-11-08 · RESPONSE-ADAPTIVE STEREOTACTIC BODY RADIOTHERAPY BOOST AFTER CONCURRENT CHEMORADIOTHERAPY IN UNRESECTABLE STAGE III NSCLC: A PROSPECTIVE SINGLE-CENTRE COHORT STUDY. — include
- 2026-11-08 · Deep learning-based segmentation of the ischemic core and severe hypodensity on noncontrast head CT compared with CT perfusion and diffusion-weighted imaging. — include
- 2026-11-08 · Steering the immune response: cancer vaccines and the next era of cancer immunotherapy. — include · 📎 Zotero에 추가 (OA/gold)
- 2026-11-08 · Integrated tumor and circulating immune profiling in the NEO-CESQ trial of perioperative cemiplimab for resectable cutaneous squamous cell carcinoma. — include · 📎 Zotero에 추가 (OA/gold)
- 2026-11-08 · Pretransplant Pulmonary Hemodynamics, Explant Histology, and Primary Graft Dysfunction after Lung Transplantation for Silicosis. — include · 📎 Zotero에 추가 (OA/hybrid)
- 2026-11-08 · Adverse events in placebo arms of phase III lung cancer trials: a systematic review and meta-analysis. — include · 📎 Zotero에 추가 (OA/hybrid)